Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Notes Payables (2019 - 2025)

Historic Notes Payables for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $11000.0.

  • Biodesix's Notes Payables fell 6206.9% to $11000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $11000.0, marking a year-over-year decrease of 6206.9%. This contributed to the annual value of $21000.0 for FY2024, which is 5882.35% down from last year.
  • Biodesix's Notes Payables amounted to $11000.0 in Q3 2025, which was down 6206.9% from $16000.0 recorded in Q2 2025.
  • In the past 5 years, Biodesix's Notes Payables ranged from a high of $14.3 million in Q3 2022 and a low of $11000.0 during Q3 2025
  • In the last 5 years, Biodesix's Notes Payables had a median value of $49000.0 in 2022 and averaged $1.7 million.
  • In the last 5 years, Biodesix's Notes Payables tumbled by 9992.48% in 2021 and then soared by 7157000.0% in 2022.
  • Quarter analysis of 5 years shows Biodesix's Notes Payables stood at $19000.0 in 2021, then soared by 157.89% to $49000.0 in 2022, then increased by 4.08% to $51000.0 in 2023, then plummeted by 58.82% to $21000.0 in 2024, then tumbled by 47.62% to $11000.0 in 2025.
  • Its Notes Payables was $11000.0 in Q3 2025, compared to $16000.0 in Q2 2025 and $18000.0 in Q1 2025.